Innovation in Medicinal Chemistry: Unlocking Unsolved Diseases
From AI to PROTACs, Darryl McConnell and Jürgen Mack explain how our teams leverage cutting-edge approaches aiming to bring ‘undruggable’ targets within reach.
Vienna, Austria, is a cornerstone within the company’s global R&D network, with a special focus on cancer research. On top of that, it is also a hub for biopharmaceutical development and production.